ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.5700
+0.0200 (3.64%)
At close: Mar 20, 2026

ZYUS Life Sciences Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.470.480.350.3-0
Revenue Growth (YoY)
2.88%37.04%17.79%---38.56%
Cost of Revenue
0.240.210.150.1--0
Gross Profit
0.060.130.17-0.23-0
Selling, General & Admin
7.968.6712.018.68--
Depreciation & Amortization Expenses
2.892.963.114.05--
Research & Development
2.042.051.312.21--
Other Operating Expenses
0.9621.5927.884.05--
Total Operating Expenses
13.8535.2744.3118.9900
Operating Income
-33.92-34.99-42.14-18.79-0
Interest Income
0.46---0.58-0.52
Interest Expense
-1.94-1.08-3.85-5.46--
Other Non-Operating Income (Expense)
-1.25-0.35-1.9-6.81--
Total Non-Operating Income (Expense)
-2.74-1.43-5.74-12.280.58-0.52
Pretax Income
-35.78-35.89-48.44-24.720.35-0.73
Provision for Income Taxes
-2.04-2.09-5.85-0.06--
Net Income
-33.74-33.81-42.59-24.660.35-0.73
Net Income to Common
-33.74-33.81-42.59-24.660.35-0.73
Shares Outstanding (Basic)
7672563855
Shares Outstanding (Diluted)
7672563855
Shares Change (YoY)
6.47%28.41%45.82%665.26%--
EPS (Basic)
-0.46-0.47-0.76-0.640.07-0.14
EPS (Diluted)
-0.46-0.47-0.76-0.640.07-0.14
Free Cash Flow
-12.61-9.92-18.23-10.13-0.33-0.02
Free Cash Flow Per Share
-0.17-0.14-0.32-0.26-0.07-0.00
Gross Margin
13.12%26.82%48.72%-77.85%-257.09%
Operating Margin
-7295.27%-7274.84%-12005.98%-6306.04%-257.09%
Profit Margin
-7256.77%-7028.07%-12134.19%-8274.16%--294931.58%
FCF Margin
-2712.47%-2062.79%-5193.45%-3400.67%--8779.35%
EBITDA
-31.04-32.03-39.04-14.7500
EBITDA Margin
-6674.84%-6659.25%-11121.08%-4948.66%-257.09%
EBIT
-33.92-34.99-42.14-18.79-0
EBIT Margin
-7295.27%-7274.84%-12005.98%-6306.04%-257.09%
Effective Tax Rate
5.69%5.82%12.07%0.23%0.00%0.00%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.